Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibiting the NLRP3 Inflammasome
Lina Y. El‐Sharkawy, David Brough, Sally Freeman
Molecules (2020) Vol. 25, Iss. 23, pp. 5533-5533
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
Hallie Blevins, Yiming Xu, Savannah Biby, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 259
Neuroinflammation in Alzheimer’s Disease
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 204
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
Dobromir Dobrev, Jordi Heijman, Roddy Hiram, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 3, pp. 145-167
Open Access | Times Cited: 149
How location and cellular signaling combine to activate the NLRP3 inflammasome
Anil Akbal, Alesja Dernst, Marta Lovotti, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 11, pp. 1201-1214
Open Access | Times Cited: 122
Context-dependent functions of pattern recognition receptors in cancer
Si Ming Man, Brendan J. Jenkins
Nature reviews. Cancer (2022) Vol. 22, Iss. 7, pp. 397-413
Closed Access | Times Cited: 84
Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation
Jian Gu, Xiaozhang Xu, Xiangyu Li, et al.
Oncogene (2024) Vol. 43, Iss. 31, pp. 2389-2404
Open Access | Times Cited: 21
Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases
Guang‐Ming Ren, Jian Li, Xiaochun Zhang, et al.
Science Immunology (2021) Vol. 6, Iss. 58
Closed Access | Times Cited: 62
The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets
Rongrong Bai, Yue Lang, Jie Shao, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110181-175909142110181
Open Access | Times Cited: 61
H. pylori CagA activates the NLRP3 inflammasome to promote gastric cancer cell migration and invasion
Xiaoyi Zhang, Chao Li, Dingyu Chen, et al.
Inflammation Research (2021) Vol. 71, Iss. 1, pp. 141-155
Closed Access | Times Cited: 56
MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes
Saba Bakhshi, Saeedeh Shamsi
International Immunopharmacology (2022) Vol. 106, pp. 108595-108595
Closed Access | Times Cited: 53
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
Julia Barczuk, Natalia Siwecka, Weronika Lusa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8979-8979
Open Access | Times Cited: 46
Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
Bora Tastan, Burak I. Ariöz, Şermin Genç
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Immunity against Moraxella catarrhalis requires guanylate‐binding proteins and caspase‐11‐NLRP3 inflammasomes
Daniel Enosi Tuipulotu, Shouya Feng, Abhimanu Pandey, et al.
The EMBO Journal (2023) Vol. 42, Iss. 6
Open Access | Times Cited: 22
The NLRP3 inflammasome as a target for sensorineural hearing loss
Grace E. Gregory, Kevin J. Munro, Kevin N. Couper, et al.
Clinical Immunology (2023) Vol. 249, pp. 109287-109287
Open Access | Times Cited: 22
Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions
Megh Pravin Vithalkar, Shaili Pradhan, K. Sandra, et al.
Cell Biochemistry and Biophysics (2025)
Open Access | Times Cited: 1
Oxalate nephropathy: a review
Jordan L. Rosenstock, Tatyana M J Joab, Maria V. DeVita, et al.
Clinical Kidney Journal (2021) Vol. 15, Iss. 2, pp. 194-204
Open Access | Times Cited: 42
Pyroptosis and Its Regulation in Diabetic Cardiomyopathy
Yafang Lu, Yaqiong Lu, Jun Meng, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 30
Electroacupuncture Inhibits NLRP3 Activation by Regulating CMPK2 After Spinal Cord Injury
Yi Chen, Lei Wu, Mengting Shi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
The NLRP3 inflammasome: role in the pathobiology of chronic pain
Chen Chen, Maree T. Smith
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1589-1603
Open Access | Times Cited: 21
Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation
Simone Gastaldi, Carmine Rocca, Eleonora Gianquinto, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115542-115542
Open Access | Times Cited: 18
Panaxydol extracted from Panax ginseng inhibits NLRP3 inflammasome activation to ameliorate NASH-induced liver injury
Mi‐Yeon Kim, Birang Jeong, Geun‐Shik Lee, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111565-111565
Open Access | Times Cited: 7
Nutraceutical Strategies for Suppressing NLRP3 Inflammasome Activation: Pertinence to the Management of COVID-19 and Beyond
Mark F. McCarty, Simon Bernard Iloki Assanga, Lidianys María Lewis Luján, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 47-47
Open Access | Times Cited: 45
Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression
Vincenzo Quagliariello, Massimiliano Berretta, Simona Buccolo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 37
Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors
Manas Kinra, Madhavan Nampoothiri, Devinder Arora, et al.
Scandinavian Journal of Immunology (2021) Vol. 95, Iss. 2
Open Access | Times Cited: 33
The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy
Yukun Liu, Dongfang Wang, Tianyu Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top